AI assistant
SSY Group Limited — Board/Management Information 2011
Oct 17, 2011
50335_rns_2011-10-17_07eb2c46-4816-4b45-8727-5ec9d1a7a0d2.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
==> picture [283 x 113] intentionally omitted <==
(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 2005)
RESIGNATION OF NON-EXECUTIVE DIRECTOR
The board of directors (the “ Board ”) of Lijun International Pharmaceutical (Holding) Co., Ltd (the “ Company ”) announces that Mr. Liu Zhiyong (“ Mr. Liu ”) has resigned as an nonexecutive director of the Company with effect from 16 October 2011 in order to devote more time to his other business commitments.
Mr. Liu has confirmed that there is no disagreement between him and the Board or the Company and there are no matters relating to his resignation that need to be brought to the attention of the shareholders of the Company or The Stock Exchange of Hong Kong Limited.
The Board would like to take this opportunity to express its appreciation to Mr. Liu for his valuable contribution to the Company during his tenure of office as a non-executive director of the Company.
By order of the Board Chow Hing Yeung Company Secretary
Hong Kong, 17 October 2011
As at the date of this announcement, the Board comprises Mr. Wu Qin, Mr. Qu Jiguang, Mr. Xie Yunfeng, Mr. Huang Chao, Mr. Wang Xianjun, Mr. Duan Wei, Ms. Zhang Guifu, Mr. Bao Leyuan and Ms. Gao Shuping as executive Directors, and Mr. Wang Yibing, Mr. Leung Chong Shun and Mr. Chow Kwok Wai as independent non-executive Directors.
1